# Sumar Biotech LLP – FDA Inspection, Sep 25, 2026

Source: https://www.keypedia.com/records/fda_inspections/sumar-biotech-llp/17603e9c-d72c-4962-aaef-38b36459feab
Source feed: FDA_Inspections

> FDA inspection 1337944 of Sumar Biotech LLP, September 25, 2026. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1337944
- Company Name: Sumar Biotech LLP
- Inspection Date: 2026-09-25
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- [FDA Inspection 1228623 - 2024-01-12](https://www.keypedia.com/records/fda_inspections/sumar-biotech-llp/02cc3c56-4ca4-460c-826e-e88d74388c1f)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/tanya-r-syffrard/a78a42b3-6cef-46d9-9698-ec6082956477)

Company: https://www.keypedia.com/companies/sumar-biotech-llp/b7f7f99f-fc7d-45c1-a2dd-699348bd0f42

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8